Biomea Fusion, Inc.
BMEA
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$22M
▲ +55.4% YoY
Op. Margin
–
ROIC
-219.79%
▼ -49.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$44M
▲ +41.5% YoY
Op. Cash Flow (TTM)
-$44M
▲ +41.3% YoY
Net Debt
-$26M
Net Cash Position
Cash & Equiv.
$26M
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with BMEA
Biomea Fusion (BMEA) in two numbers
Questions about Biomea Fusion
Is Biomea Fusion (BMEA) overvalued?
Biomea Fusion trades at 28.70 times earnings. Intrinsiqq's fair value calculator has no opening value for BMEA, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.
Does Biomea Fusion (BMEA) pay a dividend?
No. Biomea Fusion (BMEA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 29 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in BMEA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing BMEA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.